Cue Biopharma CUE Earnings Call Transcripts

NASDAQ CUE
$18.66 -0.10 (-0.53%)
At close: Nov 11, 2026 · 4:00 PM EST
1 earnings call on file for Cue Biopharma, Q1 2020. Each transcript opens in a new tab.
Latest earnings call

Cue Biopharma Q1 2020 Earnings Call

May 19, 2020 11,611 words · 50 min read
  • Ashley R. RobinsonInvestor Relations
  • Dan PasseriChief Executive Officer
  • Kenneth PientaActing Chief Medical Officer
  • Anish SuriPresident and Chief Scientific Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Cue Biopharma Earnings Call Transcripts

Calls1
LatestMay 19, 2020
SinceQ1 2020

Fiscal 2020

All 1 Cue Biopharma transcript Register to get access to Cue Biopharma’s earnings call transcripts.